Expertise in
3
conditions

Wendy I. Sligl

Edmonton, AB, CA 
Expertise in
3
conditions
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Wendy Sligl practices in Edmonton, Canada. Ms. Sligl is highly rated in 3 conditions, according to our data. Her top areas of expertise are Pneumonia, Toxic Megacolon, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Lung Transplant.

Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Edmonton, AB, Canada
Other Locations
Calgary, AB, Canada
Toronto, ON, Canada
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
Enrollment Status: Unknown
Publish Date: October 13, 2023
Intervention Type: Drug
Study Drugs: IFN-Beta1a, Remdesivir
Study Phase: Phase 3
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

73 Total Publications

Stakeholder perspectives on the reduction of opioid exposure in ICU: A modified Delphi survey.
Stakeholder perspectives on the reduction of opioid exposure in ICU: A modified Delphi survey.
Journal: Intensive & critical care nursing
Published: January 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sligl's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile